ArticleMicrobiome2025
Rumen microbial dysbiosis is associated with productive lifespan decline in dairy cows via metabolic-inflammatory crosstalk.
Article in Microbiome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrative microbiome and transcriptome analyses identify parity-associated alterations in rectal fecal microbiota and peripheral immune transcriptional signatures in dairy cows.BMC microbiology · 2026Observational
- Multi-omics analysis of soy isoflavone-induced responses in rumen fermentation, endocrine status and milk production in cows with varying milk yields.Journal of animal science and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundGut microbiota has been established as a critical regulator of human longevity, but the mechanistic role of rumen microbiota in dairy cow productive lifespan remains unexplored. This study investigated differences in rumen microbial community structure and metabolic signatures in a longitudinal cohort of dairy cows with divergent productive lifespans, aiming to elucidate the correction and potential regulatory mechanisms governing dairy cow longevity through microbial-host metabolic reprogramming.
resultsOur longitudinal study identified critical trends linked to increasing parity in dairy cows: milk yield and rumen microbiota diversity declined progressively, with microbial communities restructuring to show 37% higher abundance of Alphaproteobacteria and Pseudomonadota in cows with ≥ 4 parities compared to younger cohorts (parities 1-3). A key parity threshold was observed at the 4th lactation: early-parity cows (1-3) maintained energy-efficient metabolism via glycolysis/gluconeogenesis and TCA cycle, while ≥ 4th parity cows exhibited fundamental metabolic shifts-including altered methane-related gene expression, fermentation profile transitions from propionate- to acetate-dominated VFAs, and lipid dysregulation-alongside impaired nutrient conversion efficiency despite active B vitamin biosynthesis. These changes triggered pro-inflammatory metabolite accumulation, leading to systemic inflammation (elevated IL-1β/TNF-α/IL-6 levels) and reduced antioxidant capacity. Murine rumen microbiota transplantation experiments confirmed causality, with recipients of ≥ 4th parity microbiota developing gut barrier dysfunction and hepatic inflammation via TLR4/NF-κB pathway activation.
conclusionLongitudinal analyses classify rumen microbial dysbiosis as a potential driver of reduced productive longevity and lactation performance decline in dairy cows, suggesting that the temporal dynamics of the rumen microbiota influence lactation persistence and productive lifespan. This study fills the gap in microbiota-targeted strategies to extend dairy cows' productive longevity through precision microbial consortium modulation. Video Abstract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.